Isquemia arterial bilateral espontánea de extremidades inferiores por COVID-19 leve
Spontaneous bilateral lower limb arterial ischemia due to mild COVID-19
Contenido principal del artículo
Resumen
Introducción: la infección por COVID-19 ocasiona neumonía como parte del síndrome respiratorio agudo severo Coronavirus 2 (SARS-CoV-2), abarca desde la enfermedad asintomática y leve hasta una condición crítica y grave, mediada por una respuesta inmune disregulada. Presentación del caso: paciente masculino de 47 años procedente del área urbana sin antecedentes de importancia. Acudió a la sala de urgencias de un centro hospitalario refiriendo dolor en miembros inferiores de 3 días de evolución. Manifestó que en días previos presentó sintomatología respiratoria leve. Se tomó prueba para SARS-CoV-2 con resultado positivo. Se practicó dúplex arterial de miembros inferiores que mostró adecuado flujo sanguíneo con obstrucción completa en partes distales. Discusión y conclusiones: se reporta el caso de un paciente con COVID-19 leve que sufrió isquemia arterial espontánea en los miembros inferiores con requerimiento de amputación. Se enfatiza en las presuntas teorías como la inmunotrombosis y la disfunción endotelial que expliquen los mecanismos causantes de esta complicación.
Palabras clave:
Descargas
Detalles del artículo
Referencias
Chen, T., Wu, D., Chen, H., Yan, W., Yang, D., Chen, G., et al. Clinical characteristics of 113 deceased patients with coronavirus disease 2019: retrospective study. BMJ [Internet]. 2020;368, m1091. Disponible en: 10.1136/bmj.m1091 DOI: https://doi.org/10.1136/bmj.m1091
Wang D, Hu B, Hu C, Zhu F, Liu X, Zhang J, Wang B, Xiang H, Cheng Z, Xiong Y, Zhao Y, Li Y, Wang X, Peng Z. Clinical characteristics of 138 hospitalized patients with 2019 novel coronavirus-infected pneumonia in Wuhan, China. JAMA [Internet]. 2020; Disponible en: 10.1001/jama.2020.1585 DOI: https://doi.org/10.1001/jama.2020.1585
Y. Rodríguez, et al. Autoinflammatory and autoimmune conditions at the crossroad of COVID- 19. J Autoimmun [Internet]. 114 (2020) 102506. Disponible en: https://doi.org/10.1016/j.jaut.2020.102506 DOI: https://doi.org/10.1016/j.jaut.2020.102506
Wu Z, Mcgoogan JM. Characteristics of and important lessons from the coronavirus disease 2019 (COVID-19) outbreak in China. JAMA. 2020;323:1239. DOI: https://doi.org/10.1001/jama.2020.2648
Y. Zuo, S. Yalavarthi, H. Shi, K. Gockman, M. Zuo, J.A. Madison, C. Blair,, A. Weber, B.J. Barnes, M. Egeblad, R.J. Woods, Y. Kanthi, J.S. Knight. Neutrophil extracellular traps (NETs) as markers of disease severity in COVID-19. MedRxiv [Internet]. 2020; Disponible en: https://doi.org/10.1101/2020.04.09.20059626 In press DOI: https://doi.org/10.1101/2020.04.09.20059626
N. Sethuraman, S.S. Jeremiah, A. Ryo. Interpreting diagnostic tests for SARS-CoV- 2. J Am Med Assoc [Internet]. 323 (22) (2020) 2249-2251. Disponible en: https://doi.org/10.1001/jama. 2020.8259 In press DOI: https://doi.org/10.1001/jama.2020.8259
M.Z. Tay, C.M. Poh, L. Rénia, P.A. MacAry, L.F.P. Ng. The trinity of COVID-19: immunity, inflammation and intervention. Nat Rev Immunol [Internet]. 20 (2020) 363-374. Disponible en: https://doi.org/10.1038/s41577-020-0311-8 In press. DOI: https://doi.org/10.1038/s41577-020-0311-8
Q.-X. Long, B.-Z. Liu, H.-J. Deng, G.-C. Wu, K. Deng, Y.-K. Chen, P. Liao, J.-F. Qiu, Y. Lin, X.-F. Cai, D.-Q. Wang, Y. Hu, J.-H. Ren, N. Tang, Y.-Y. Xu, L.-H. Yu, Z. Mo, F. Gong, X.-L. Zhang, W.-G. Tian, L. Hu, X.-X. Zhang, J.-L. Xiang, H.-X. Du, H.-, W. Liu, C.-H. Lang, X.-H. Luo, S.-B. Wu, X.-P. Cui, Z. Zhou, M.-M. Zhu, J. Wang, C.-, J. Xue, X.-F. Li, L. Wang, Z.-J. Li, K. Wang, C.-C. Niu, Q.-J. Yang, X.-J. Tang, Y. Zhang, X.-M. Liu, J.-J. Li, D.-C. Zhang, F. Zhang, P. Liu, J. Yuan, Q. Li, J.-L. Hu, et al. Antibody responses to SARS-CoV-2 in patients with COVID- 19. Nat Med [Internet]. 2020; Disponible en: https://doi.org/10.1038/s41591-020-0897-1 In press. DOI: https://doi.org/10.1038/s41591-020-0897-1
S.Q. Du, W. Yuan. Mathematical modeling of interaction between innate and adaptive immune responses in COVID‐19 and implications for viral pathogenesis. J Med Virol [Internet]. 2020; Disponible en: https://doi.org/10.1002/jmv.25866 In press jmv.25866 DOI: https://doi.org/10.1002/jmv.25866
Bonaventura, A., Vecchié, A., Dagna, L., Martinod, K., Dixon, D. L., Van Tassell, B. W., Dentali, F., Montecucco, F., Massberg, S., Levi, M., & Abbate, A. Endothelial dysfunction and immunothrombosis as key pathogenic mechanisms in COVID-19. Nat Rev Immunol. 2021;21(5), 319-329. DOI: https://doi.org/10.1038/s41577-021-00536-9
Jin Y, Ji W, Yang H, Chen S, Zhang W, Duan G. Endothelial activation and dysfunction in COVID-19: from basic mechanisms to potential therapeutic approaches. Signal Transduct Target Ther. 2020;24;5(1):293. DOI: https://doi.org/10.1038/s41392-020-00454-7
Iba, T., Levy, J. H., Levi, M., Connors, J. M. & Thachil, J. Coagulopathy of coronavirus disease 2019. Crit Care Med. 2020;48, 1358-1364. DOI: https://doi.org/10.1097/CCM.0000000000004458
Kaur P, Qaqa F, Ramahi A, Shamoon Y, Singhal M, Shamoon F, Maroules M, Singh B. Acute upper limb ischemia in a patient with COVID-19. Hematol Oncol Stem Cell Ther. 2020;13:S1658-3876(20)30096-0.
Xiong M, Liang X, Wei YD. Changes in blood coagulation in patients with severe coronavirus disease 2019 (COVID‐19): a meta‐analysis. Br J Haematol. 2020;189: 1050-1052. DOI: https://doi.org/10.1111/bjh.16725
Cui S, Chen S, Li X, Liu S, Wang F. Prevalence of venous thromboembolism in patients with severe novel coronavirus pneumonia. J Thromb Haemost [Internet]. 2020;18: 1421-1424. Disponible en: https://doi.org/10.1111/jth.14830 DOI: https://doi.org/10.1111/jth.14830
Klok FA, Kruip MJHA, van der Meer NJM, Arbous MS, Gommers, DAMPJ, Kant KM, et al. Confirmation of the high cumulative incidence of thrombotic complications in critically ill ICU patients with COVID-19. Thromb Res. 2020;191:148-150. DOI: https://doi.org/10.1016/j.thromres.2020.04.041
Liwinski, T., Zheng, D. & Elinav, E. The microbiome and cytosolic innate immune receptors. Immunol Rev [Internet]. 2020; Disponible en: https://doi.org/10.1111/imr.12901 DOI: https://doi.org/10.1111/imr.12901
Toldo, S., Bussani, R., Nuzzi, V., Bonaventura, A., Mauro, A. G., Cannatà, A., Pillappa, R., Sinagra, G., Nana-Sinkam, P., Sime, P., & Abbate, A. Inflammasome formation in the lungs of patients with fatal COVID-19. Inflamm Res Off J Eur Histamine Res Soc. 2021;70(1), 7-10. DOI: https://doi.org/10.1007/s00011-020-01413-2
Rodrigues, T. S., de Sá, K., Ishimoto, A. Y., Becerra, A., Oliveira, S., Almeida, L., Gonçalves, A. V., Perucello, D. B., Andrade, W. A., Castro, R., Veras, F. P., Toller-Kawahisa, J. E., Nascimento, D. C., de Lima, M., Silva, C., Caetite, D. B., Martins, R. B., Castro, I. A., Pontelli, M. C., de Barros, F. C., Zamboni, D. S. Inflammasomes are activated in response to SARS-CoV-2 infection and are associated with COVID-19 severity in patients. J Exp Med. 2021;218(3), e20201707. DOI: https://doi.org/10.1084/jem.20201707
Goeijenbier, M., van Wissen, M., van de Weg, C., Jong, E., Gerdes, V. E., Meijers, J. C., Brandjes, D. P., & van Gorp, E. Review: Viral infections and mechanisms of thrombosis and bleeding. J Med Virol [Internet]. 2012;84(10), 1680-1696. Disponible en: https://doi.org/10.1002/jmv.23354 DOI: https://doi.org/10.1002/jmv.23354
Godo, S. & Shimokawa, H. Endothelial functions. Arter Thromb Vasc Biol. 2017;37, 108-114. DOI: https://doi.org/10.1161/ATVBAHA.117.309813
Sturtzel, C. Endothelial cells. Adv Exp Med Biol. 2017;1003, 71-91. DOI: https://doi.org/10.1007/978-3-319-57613-8_4
Kruger-Genge, A., Blocki, A., Franke, R. P. & Jung, F. Vascular endothelial cell biology: an update. Int J Mol Sci. 2019;20, 4411. DOI: https://doi.org/10.3390/ijms20184411
Escher, R., Breakey, N. & Lammle, B. Severe COVID-19 infection associated with endothelial activation. Thromb Res. 2020;190, 62. DOI: https://doi.org/10.1016/j.thromres.2020.04.014
Green, S. J. Covid-19 accelerates endothelial dysfunction and nitric oxide deficiency. Microbes Infect. 2020;22, 149-150. DOI: https://doi.org/10.1016/j.micinf.2020.05.006
Pober, J. S. & Sessa, W. C. Evolving functions of endothelial cells in inflammation. Nat Rev Immunol. 2007;7, 803-815. DOI: https://doi.org/10.1038/nri2171
Akerstrom, S. et al. Nitric oxide inhibits the replication cycle of severe acute respiratory syndrome coronavirus. J Virol. 2005;79, 1966-1969. DOI: https://doi.org/10.1128/JVI.79.3.1966-1969.2005
Akerstrom, S., Gunalan, V., Keng, C. T., Tan, Y. J. & Mirazimi, A. Dual effect of nitric oxide on SARS-CoV replication: viral RNA production and palmitoylation of the S protein are affected. Virology. 2009;395, 1-9. DOI: https://doi.org/10.1016/j.virol.2009.09.007
Panigada, M. et al. Hypercoagulability of COVID-19 patients in intensive care unit: a report of thromboelastography findings and other parameters of hemostasis. J Thromb Haemost. 2020;18, 1738-1742. DOI: https://doi.org/10.1111/jth.14850
Ranucci, M. et al. The procoagulant pattern of patients with COVID-19 acute respiratory distress syndrome. J Thromb Haemost. 2020;18, 1747-1751. DOI: https://doi.org/10.1111/jth.14854
Ciceri, F. et al. Microvascular COVID-19 lung vessels obstructive thromboinflammatory syndrome (MicroCLOTS): an atypical acute respiratory distress syndrome working hypothesis. Crit Care Resusc. 2020;22, 95-97.
Gattinoni, L., Chiumello, D., Caironi, P., Busana, M., Romitti, F., Brazzi, L., & Camporota, L. COVID-19 pneumonia: different respiratory treatments for different phenotypes? Intensive Care Med. 2020;46(6);1099-1102. DOI: https://doi.org/10.1007/s00134-020-06033-2
Zuo, Y., Estes, S. K., Ali, R. A., Gandhi, A. A., Yalavarthi, S., Shi, H., Sule, G., Gockman, K., Madison, J. A., Zuo, M., Yadav, V., Wang, J., Woodard, W., Lezak, S. P., Lugogo, N. L., Smith, S. A., Morrissey, J. H., Kanthi, Y., & Knight, J. S. Prothrombotic autoantibodies in serum from patients hospitalized with COVID-19. Sci Transl Med [Internet]. 2020;12(570), eabd3876. Disponible en: https://doi.org/10.1126/scitranslmed.abd3876 DOI: https://doi.org/10.1126/scitranslmed.abd3876